BioNTech began construction for the initial mRNA manufacturing facility in Kigali, Rwanda, with a target for the first set of manufacturing BioNTainers to be delivered to the site by the end of 2022. The company expects to set up additional factories in Senegal and South Africa in close coordination with its partners in the respective countries. The initial site will become a node in a decentralized end-to-end manufacturing network in Africa. All vaccines to be manufactured in the network will b...